Orange Book product · Brand (NDA)
CATAPRES-TTS-1
CLONIDINE
At a glance
Oct 10, 1984
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 10, 1984
42 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
CLONIDINE
Strength
0.1MG/24HR
Dosage form
SYSTEM
Route
TRANSDERMAL
TE code
AB
Application
NDA 018891
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2009CLONIDINEBrand (NDA)
NDA 022499 · TRIS PHARMA INC
- 2009NEXICLON XRBrand (NDA)
NDA 022500 · ROSEMONT
- 2014CLONIDINEGeneric (ANDA)
ANDA 090873 · ACTAVIS LABS UT INC
- 2010CLONIDINEGeneric (ANDA)
ANDA 079090 · DR REDDYS LABS SA
- 2010CLONIDINEGeneric (ANDA)
ANDA 076166 · MYLAN TECHNOLOGIES
- 2009CLONIDINEGeneric (ANDA)
ANDA 076157 · DIFGEN PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
